Filtros de búsqueda

Lista de obras de

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

artículo científico publicado en 2017

A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease

artículo científico publicado en 2010

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

artículo científico publicado en 2014

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms

scholarly article by Sebastian Palmqvist et al published 23 October 2018 in Alzheimer's and Dementia

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

artículo científico publicado en 2014

Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease

artículo científico publicado en 2020

Biomarker testing in MCI patients-deciding who to test

artículo científico publicado en 2021

Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study

scientific article published on 13 September 2019

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

artículo científico publicado en 2020

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

artículo científico publicado en 2016

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

scientific article published on 11 November 2019

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

scientific article published on 17 August 2016

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

artículo científico publicado en 2018

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

artículo científico publicado en 2012

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

artículo científico publicado en 2015

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease

artículo científico publicado en 2020

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

scientific article published on 11 July 2018

Gender-dependent levels of hyaluronic acid in cerebrospinal fluid of patients with neurodegenerative dementia

artículo científico publicado en 2012

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis

artículo científico publicado en 2016

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia

artículo científico publicado en 2020

Plasma tau in Alzheimer disease

scientific article published on 30 September 2016

Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests

artículo científico publicado en 2009

The impact of demographic, clinical, genetic, and imaging variables on tau PET status

scientific article published on 19 November 2020

The usefulness of cube copying for evaluating treatment of Alzheimer's disease.

artículo científico publicado en 2008